Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the University of South Wales, UK. He has over 16 years of experience and has authored numerous publications and conference presentations across law and emerging technologies.Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise in pharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, and is listed among the world’s Top 2% Scientists per Stanford University.Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses on intellectual property and emerging technologies, particularly artificial intelligence and innovation policy.Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health Sciences University, UAE, with over 25 years of experience in clinical pharmacy and pharmacovigilance research.

“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

• 1. Gene Editing Governance and Genetic Engineering: A Framework for Regulating CRISPR Technology 2. Application and Challenges of the CRISPR/Cas9 System for Gene Editing 3. Impact of Genomics on Drug Discovery and Clinical Medicine on Public Healthcare: Fostering Disease Prevention and Enhancing Human Well-Being. 4. Challenges and Approaches to Human Genome Editing 5. Precision Medicine Through Gene Editing: Pharmacogenomics and the Future of Disease Management in Clinical Healthcare 6. Patenting the Genome: A Global Perspective of Intellectual Property Rights and Genetic Innovation 7. Biosafety Issues Relating to Genome Editing in Plants and its Impact on Human Health 8. Gene Editing and Human Rights: Legal Implications of CRISPR Technology 9. Genomic Innovations in Drug Discovery and Clinical Medicine 10. Impact of Genomics on Drug Discovery and Clinical Medicine: Fostering Gene Editing and Personalized Medicine, Bioinformatics and Artificial Intelligence

Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the University of South Wales, UK. He has over 16 years of experience and has authored numerous publications and conference presentations across law and emerging technologies.Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise in pharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, and is listed among the world’s Top 2% Scientists per Stanford University.Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses on intellectual property and emerging technologies, particularly artificial intelligence and innovation policy.Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health Sciences University, UAE, with over 25 years of experience in clinical pharmacy and pharmacovigilance research.

“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

• 1. Gene Editing Governance and Genetic Engineering: A Framework for Regulating CRISPR Technology 2. Application and Challenges of the CRISPR/Cas9 System for Gene Editing 3. Impact of Genomics on Drug Discovery and Clinical Medicine on Public Healthcare: Fostering Disease Prevention and Enhancing Human Well-Being. 4. Challenges and Approaches to Human Genome Editing 5. Precision Medicine Through Gene Editing: Pharmacogenomics and the Future of Disease Management in Clinical Healthcare 6. Patenting the Genome: A Global Perspective of Intellectual Property Rights and Genetic Innovation 7. Biosafety Issues Relating to Genome Editing in Plants and its Impact on Human Health 8. Gene Editing and Human Rights: Legal Implications of CRISPR Technology 9. Genomic Innovations in Drug Discovery and Clinical Medicine 10. Impact of Genomics on Drug Discovery and Clinical Medicine: Fostering Gene Editing and Personalized Medicine, Bioinformatics and Artificial Intelligence

Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at the University of South Wales, UK. He has over 16 years of experience and has authored numerous publications and conference presentations across law and emerging technologies.Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise in pharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, and is listed among the world’s Top 2% Scientists per Stanford University.Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses on intellectual property and emerging technologies, particularly artificial intelligence and innovation policy.Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and Health Sciences University, UAE, with over 25 years of experience in clinical pharmacy and pharmacovigilance research.

“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

• 1. Gene Editing Governance and Genetic Engineering: A Framework for Regulating CRISPR Technology 2. Application and Challenges of the CRISPR/Cas9 System for Gene Editing 3. Impact of Genomics on Drug Discovery and Clinical Medicine on Public Healthcare: Fostering Disease Prevention and Enhancing Human Well-Being. 4. Challenges and Approaches to Human Genome Editing 5. Precision Medicine Through Gene Editing: Pharmacogenomics and the Future of Disease Management in Clinical Healthcare 6. Patenting the Genome: A Global Perspective of Intellectual Property Rights and Genetic Innovation 7. Biosafety Issues Relating to Genome Editing in Plants and its Impact on Human Health 8. Gene Editing and Human Rights: Legal Implications of CRISPR Technology 9. Genomic Innovations in Drug Discovery and Clinical Medicine 10. Impact of Genomics on Drug Discovery and Clinical Medicine: Fostering Gene Editing and Personalized Medicine, Bioinformatics and Artificial Intelligence